Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-1-4
pubmed:abstractText
Immunization with exogenous proteins usually fails to immunize CD8+ T cells in vivo. Here we report that chicken ovalbumin (OVA) denatured by heat or sodium dodecyl sulphate (SDS) effectively induced CD8+ cytolytic T cells in vivo. The cytolytic T-lymphocyte (CTL) population generated recognized syngeneic target cells pulsed with the immunodominant OVA peptide (257-264) or transfected with the OVA protein-encoding gene. To analyse the mechanisms of how denatured OVA enters the class I-restricted pathway of antigen presentation, we took advantage of the fact that denatured OVA sensitizes target cells in vitro for lysis by OVA-specific CTL. We found that neither inhibition of protein synthesis (by cycloheximide) nor blocking of transport via the Golgi apparatus (by brefeldin A) interfered with the class I-restricted presentation of denatured OVA in vitro. In addition, transporter associated with antigen presentation (TAP)-dependent transport into the endoplasmic reticulum (ER) was not required for effective presentation, as TAP-deficient cells (RMA-S) could be sensitized effectively by denatured OVA for recognition by class I-restricted CTL. In contrast, class I-restricted presentation of denatured OVA was sensitive to lysosomotropic agents (NH4Cl, vinblastine and leupeptin), indicating that endosomal-like compartments are involved in the presentation of denatured OVA. Sensitization was inhibited at low temperature, yet took place in the presence of sucrose and in the absence of K+, indicating that denatured OVA enters the cell via fluid-phase endocytosis. Hence the results provide further evidence for an alternative class I-restricted pathway of antigen presentation for exogenous proteins. As that pathway seems to be effective in vivo, it offers a new and effective way of vaccination of CD8+ CTL.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-1309489, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-1312473, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-1384958, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-1386866, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-1575680, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-1602127, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-1904363, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2005381, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2026440, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2032286, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2166918, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2184369, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2270487, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2443853, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2586628, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2784478, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2785645, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-2925787, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-3261634, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-4055891, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-6147196, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-7523572, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-7679422, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-7809629, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8026512, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8077665, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8144958, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8258336, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8258337, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8293464, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8301120, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8303944, http://linkedlifedata.com/resource/pubmed/commentcorrection/7490131-8506338
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
287-95
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
pubmed:affiliation
Institute for Medical Microbiology and Hygiene, Technical University of Munich, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't